Top Menu HELP dot CONTACT US dot LOGIN  

What if millions of people could lead a better life?

CHALLENGE | Psoriasis

Psoriasis is a serious, chronic skin disease that means physical and social discomfort for people. Untreated, the psoriasis disease could lead to isolation, emotional problems and, at worst, a shorter life.

More than 100 million people worldwide have psoriasis. Only half of these patients receive proper treatment. This is not acceptable. Therefore, we see the challenges faced by people with psoriasis as our challenges.To find out how you can have a better life with psoriasis – see www.psorinfo.com.

Read more
Dedicated to Leadership in Dermatology
News
Ask your Question Ask your Question

Having questions on Osteoporosis, Renal Failure, Psoriasis, Atopic Eczema, Anticoagulation, Eye Infections, Haemodialysis, and more?


Read more
 
LEO Pharma acquires own portfolio in the US LEO Pharma acquires own portfolio in the US
LEO Pharma has re-acquired the US-rights to the company’s psoriasis portfolio and dermatology pipeline from the previous partner in the US...
Read more
 
LEO Training Academy (L.T.A.) LEO Training Academy (L.T.A.)

Behavioral Style Workshop
(Sharm El Sheikh, 24th - 30th October 2009)
Join us!


Read more
 
New drug for scalp psoriasis approved in Europe New drug for scalp psoriasis approved in Europe
Xamiol® – LEO Pharma's new drug for treatment of scalp psoriasis - has been approved in 16 European countries.
Read more
 
FDA Approves Taclonex Scalp® FDA Approves Taclonex Scalp®
- Once Daily Therapy for Treatment of Moderate to Severe Scalp Psoriasis. Warner Chilcott and LEO Pharma announced 12 May that the FDA has approved...
Read more
 
ShortCuts/Site Map ShortCuts/Site Map

Content site map


Read more
 

Login to Restricted Web Area
Email:
Password:
 
 
News
12-11-2009 - LEO Pharma Completes Peplin Acquisition
Danish LEO Pharma has gained additional ground in the US after finalising the agreement to acquire Australian-US Peplin, Inc. Read More

1-10-2009 - LEO Pharma acquires own portfolio in the US
LEO Pharma A/S, a world leader in treatment of dermatological diseases, has re-acquired the US-rights to the company’s psoriasis portfolio and dermatology pipeline from the previous partner in the US, Warner Chilcott. The transaction sum is set at... Read More

1-1-2009 - LEARN MORE ABOUT...
Patient Educational Material Read More

SITEMAP Disclaimer Privacy Policy
LEO Pharmaceutical Products Sarath LTD . 5, Himaras street . 3rd floor . GR-151 25 Marousi . Athens . Greece. Tel: +30 210 9954545 . Fax: +30 210 9940565 .
E-mail: leo.roa@leo-pharma.com